Clinical Trial Update: A Multi-center Retrospective Study of INO Treating B-ALL

View source ↗

Summary

A multi-center retrospective study evaluating Inotuzumab Ozogamicin for B-cell acute lymphoblastic leukemia, with Venetoclax as part of the treatment conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Besponsa (inotuzumab ozogamicin)
• Venclexta (venetoclax)

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Lymphoblastic Leukaemia, Acute Lymphoblastic Leukaemias (ALL) | Status: ACTIVE_NOT_RECRUITING